Thomas P. O'Neil, Chief Financial Officer at Satsuma Pharmaceuticals, Inc. (STSA), sold 4,230 shares at $35.23 ($149K) on 2020-06-23, disclosed to the SEC on 2020-06-24.
Open-market sale of $149k STSA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.23 | 2,115 | $75K | 50.0% |
| 2 | $35.23 | 2,115 | $75K | 50.0% |
| Total | $35.23 avg | 4,230 | $149K | 100% |
| Filing → |
| STSA | SELL | 2020-07-02 | $27K | — | Filing → |
| STSA | SELL | 2020-06-02 | $25K | — | Filing → |
| STSA | SELL | 2020-05-21 | $50K | — | Filing → |